Arcturus Therapeutics Holdings Stock Price on November 8, 2021

ARCT Stock  USD 32.86  0.73  2.27%   
Below is the normalized historical share price chart for Arcturus Therapeutics Holdings extending back to May 22, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcturus Therapeutics stands at 32.86, as last reported on the 28th of March, with the highest price reaching 33.00 and the lowest price hitting 31.76 during the day.
IPO Date
16th of April 2020
200 Day MA
29.6682
50 Day MA
36.0678
Beta
2.636
 
Yuan Drop
 
Covid
If you're considering investing in Arcturus Stock, it is important to understand the factors that can impact its price. We consider Arcturus Therapeutics very steady. Arcturus Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0366, which signifies that the company had a 0.0366% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Arcturus Therapeutics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Arcturus Therapeutics' risk adjusted performance of 0.0299, and Mean Deviation of 2.96 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%.
  
At this time, Arcturus Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 28 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 1.5 M in 2024. . At this time, Arcturus Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.17 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.06 in 2024. Arcturus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0366

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskARCTHuge Risk
Negative Returns

Estimated Market Risk

 3.92
  actual daily
34
66% of assets are more volatile

Expected Return

 0.14
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
2
98% of assets perform better
Based on monthly moving average Arcturus Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcturus Therapeutics by adding it to a well-diversified portfolio.
Price Book
3.1727
Enterprise Value Ebitda
(25.73)
Price Sales
5.3024
Shares Float
24.5 M
Wall Street Target Price
67.63

Arcturus Therapeutics Valuation on November 8, 2021

It is possible to determine the worth of Arcturus Therapeutics on a given historical date. On November 8, 2021 Arcturus was worth 18.35 at the beginning of the trading date compared to the closed value of 17.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcturus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Arcturus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcturus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcturus Therapeutics' related companies.
 Open High Low Close Volume
03/14/2022
  18.35    19.74    17.43    17.64    614,400  
  17.80    18.81    17.55    18.56    415,500  
Backtest Arcturus Therapeutics  |  Arcturus Therapeutics History  |  Arcturus Therapeutics Valuation Next  
Open Value
18.35
17.64
Closing Value
30.10
Upside

Arcturus Therapeutics Trading Date Momentum on November 8, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Arcturus Therapeutics Fundamentals Correlations and Trends

By evaluating Arcturus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcturus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcturus financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Arcturus Therapeutics Stock history

Arcturus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcturus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcturus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcturus Therapeutics stock prices may prove useful in developing a viable investing in Arcturus Therapeutics
Last ReportedProjected for 2024
Common Stock Shares Outstanding26.6 M28 M
Net Income Applicable To Common Shares8.4 M8.8 M

Arcturus Therapeutics Quarterly Net Working Capital

304.6 Million

Arcturus Therapeutics Stock Technical Analysis

Arcturus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Arcturus Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Arcturus Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Arcturus Therapeutics Period Price Range

Low
March 14, 2022
High

 18.35 

  

 17.64 

-0.71-3.87%

Arcturus Therapeutics March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Arcturus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcturus Therapeutics shares will generate the highest return on investment. By undertsting and applying Arcturus Therapeutics stock market strength indicators, traders can identify Arcturus Therapeutics Holdings entry and exit signals to maximize returns

Arcturus Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Arcturus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Arcturus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcturus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Arcturus Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Arcturus Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Arcturus Therapeutics Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Arcturus Therapeutics Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcturus Therapeutics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Arcturus Stock analysis

When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
6.264
Quarterly Revenue Growth
(0.81)
Return On Assets
(0.11)
Return On Equity
(0.11)
The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcturus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.